The cost-effectiveness argument for these medications strengthens when considering avoided healthcare costs from obesity-related conditions: type 2 diabetes treatment, cardiovascular interventions, joint replacements, and MASH progression
These are pathway-level associations that give you and your provider context before titration
Introduction Obesity is a global health problem and increases the risk of developing type II diabetes mellitus (T2DM), cardiovascular disease, and dyslipidemia
In the study, 51.9% of tirzepatide users and 71.5% of semaglutide users had type 2 diabetes
So if you arent comfortable self-injecting, your doctor may prescribe a weight loss pill like phentermine
Glutathione is the master antioxidant of the body and its use has much more than cosmetic enhancement